Literature DB >> 7812968

bcl-2 deficiency in mice leads to pleiotropic abnormalities: accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine.

S Kamada1, A Shimono, Y Shinto, T Tsujimura, T Takahashi, T Noda, Y Kitamura, H Kondoh, Y Tsujimoto.   

Abstract

Transgenic mice homozygously lacking in the bcl-2 gene were generated using homologous recombination in embryonal stem cells. The complete absence of Bcl-2 alpha and -beta proteins did not interfere with normal embryonic development. Abnormalities became evident after birth, although the severity varied among homozygous null mice, bcl-2-/- mice displayed pleiotropic abnormalities similar to those in the previously described bcl-2-/- mice, including growth retardation, smaller ears, short lives, polycystic kidney, atrophic thymus and spleen with accelerated apoptotic cell death of lymphocytes, and hair hypopigmentation in the second hair follicle cycle. Our bcl-2-/- mice also revealed novel defects in the small intestine, characterized by retarded development, accelerated exfoliation of epithelial cells, and very few mitotic progenitor cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7812968

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  68 in total

Review 1.  A portrait of the Bcl-2 protein family: life, death, and the whole picture.

Authors:  M Pellegrini; A Strasser
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

2.  Experimental pneumococcal meningitis: impaired clearance of bacteria from the blood due to increased apoptosis in the spleen in Bcl-2-deficient mice.

Authors:  Andreas Wellmer; Matthias von Mering; Annette Spreer; Ricarda Diem; Helmut Eiffert; Christiane Noeske; Stefanie Bunkowski; Ralf Gold; Roland Nau
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

Review 3.  Driving apoptosis-relevant proteins toward neural differentiation.

Authors:  Susana Solá; Márcia M Aranha; Cecília M P Rodrigues
Journal:  Mol Neurobiol       Date:  2012-07-01       Impact factor: 5.590

Review 4.  Attacking cancer's Achilles heel: antagonism of anti-apoptotic BCL-2 family members.

Authors:  Joseph T Opferman
Journal:  FEBS J       Date:  2015-09-15       Impact factor: 5.542

5.  Characterisation of mice lacking all functional isoforms of the pro-survival BCL-2 family member A1 reveals minor defects in the haematopoietic compartment.

Authors:  Robyn L Schenk; Selma Tuzlak; Emma M Carrington; Yifan Zhan; Susanne Heinzel; Charis E Teh; Daniel H Gray; Lin Tai; Andrew M Lew; Andreas Villunger; Andreas Strasser; Marco J Herold
Journal:  Cell Death Differ       Date:  2017-01-13       Impact factor: 15.828

6.  Loss of PKD1 and loss of Bcl-2 elicit polycystic kidney disease through distinct mechanisms.

Authors:  P Hughes; M Robati; W Lu; J Zhou; A Strasser; P Bouillet
Journal:  Cell Death Differ       Date:  2005-11-11       Impact factor: 15.828

7.  Effects of Helicobacter pylori infection on gastric epithelial cell kinetics in patients with chronic renal failure.

Authors:  Selim Aydemir; Binnaz Handan Ozdemir; Gurden Gur; Ibrahim Dogan; Ugur Yilmaz; Sedat Boyacioglu
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

Review 8.  Potential pharmacological interventions in polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Robert W Schrier
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 9.  Intracellular death platform steps-in: targeting prostate tumors via endoplasmic reticulum (ER) apoptosis.

Authors:  Steven R Schwarze; Eric W Lin; Perry A Christian; Dustin T Gayheart; Natasha Kyprianou
Journal:  Prostate       Date:  2008-11-01       Impact factor: 4.104

10.  Brief report: increased apoptosis in advanced atherosclerotic lesions of Apoe-/- mice lacking macrophage Bcl-2.

Authors:  Edward Thorp; Yankun Li; Liping Bao; Pin Mei Yao; George Kuriakose; James Rong; Edward A Fisher; Ira Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-11-06       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.